DIURIL (chlorothiazide) by Teva is clinical pharmacology the mechanism of the antihypertensive effect of thiazides is unknown. First approved in 1958.
Drug data last refreshed 14h ago · AI intelligence enriched 1mo ago
DIURIL (chlorothiazide) is an oral thiazide diuretic approved in 1958 for hypertension and edema management. It works by inhibiting electrolyte reabsorption in the distal renal tubule, increasing sodium and chloride excretion and reducing blood volume. The mechanism of its antihypertensive effect remains incompletely understood.
Minimal commercial activity with only 233 Part D claims in 2023; declining patient base signals reduced team investment and limited career growth opportunities on this brand.
CLINICAL PHARMACOLOGY The mechanism of the antihypertensive effect of thiazides is unknown. DIURIL does not usually affect normal blood pressure. DIURIL affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are approximately equal in…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide
Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions
Worked on DIURIL at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DIURIL offers limited career advancement; the product exists primarily as a generic commodity with minimal marketing spend and low patient acquisition. Roles are typically focused on compliance, supply chain, and cost management rather than innovation or market expansion.